Item 7.01. Regulation FD Disclosure.

On January 9, 2023, United Therapeutics Corporation intends to provide an overview and update on the company's business during a presentation and Q&A session at the 41st annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will include the slides furnished as Exhibit 99.1 hereto and incorporated herein by reference. These slides will also be posted to the United Therapeutics website at ir.unither.com/events-and-presentations.

As previously announced, the presentation will take place on January 9, 2023, from 1:30 p.m. to 2:10 p.m., Pacific Standard Time, and can be accessed via a live webcast on the United Therapeutics website at https://ir.unither.com/events-and-presentations. An archived, recorded version of the session will be available approximately 24 hours after the session ends and can be accessed at the same location for 30 days.

The information in this Item 7.01 and the related Item 9.01, including Exhibit 99.1 and Exhibit 99.2 attached hereto, are being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act as amended, regardless of any general incorporation language in such filing.





Item 9.01. Exhibits




(d)  Exhibits

Exhibit No.                          Description of Exhibit

  99.1          Investor presentation dated January 9, 2023
104           The cover page from this Current Report on Form 8-K, formatted in
              Inline XBRL




                                       2

© Edgar Online, source Glimpses